Focused Ultrasound for Treatment of Fibroids

Uterine fibroids are common smooth muscle tumors of myometrial cells, which can result in substantial symptoms affecting the quality of life of women. Currently, patients have several options available for treatment ranging from uterine-sparing surgeries (myomectomy), hysterectomy, and nonsurgical options, such as uterine artery embolization, magnetic resonance-guided focused ultrasound (MRgFUS), or cryoablation. MRgFUS is one of the least invasive treatment options outside medical therapy. MRgFUS ablation combines therapy delivered by an ultrasound transducer with imaging, guidance for therapy, and thermal feedback provided by magnetic resonance imaging. In 2004, the MRgFUS system ExAblate 2000 (InSightec, Haifa, Israel) was approved by the United States Food and Drug Administration for clinical treatments of uterine fibroids. Data on safety and long-term efficacy are ongoing to establish the unique usefulness of this therapy in targeted treatment of leiomyoma through the integration of MR imaging. Multiple clinical trials detail several efficacy outcomes including symptom improvement, leiomyoma shrinkage, and use of alternative procedures. Additionally, favorable pregnancy outcomes following MRgFUS have been reported. Applications of MRgFUS have recently expanded into the realm of adenomyosis treatment. MRgFUS has been deemed a safe and effective method of fibroid treatment and offers the advantages of no incisions or blood loss, speedy recovery, and a cost-effective means of treatment. Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others

Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94:435. Sakuhara Y, Shimizu T, Kodama Y, Sawada A, Endo H, Abo D, Hasegawa T, Miyasaka K. Magnetic resonance-guided percutaneous cryoablation of uterine fibroids: early clinical experiences. Cardiovasc Intervent Radiol. 2006;29(4):552–8. Breech LL, Rock JA. Leiomyomata uteri and myomectomy. In: Rock JA, Jones HW, editors. Telinde’s operative gynecology. Tenthth ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 719–21. Rabinovici J, David M, Fukunishi M, Morita Y, Stewart EA, MRgFUS Study Group. MR guided focused ultrasound pregnancies: pregnancy outcome following magnetic resonance guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril. 2008;93(1):199–209. Stovall DW. Alternatives to hysterectomy: focus on global endometrial ablation, uterine fibroid embolization, and magnetic resonance-guided focused ultrasound. Menopause. 2011;18(4):443–50. Fennessy FM, Tempany CM, McDannold NJ, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery-results of different treatment protocols. Radiology. 2007;243(3):885–93. Hindley J, Gedroyc W, Regan L, Stewart E, Tempany C, et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol. 2004;183(6):1713–9. Abdullah B, Subramaniam R, Omar S, Wragg P, Ramli N, Wui A, Lee C, Yusof Y. Magnetic resonance-guided focused ultrasound surgery (MRgFUS) treatment for uterine fibroids. Biomed Imaging Interv J. 2010;6(2):e15. Epub 2010 Apr 1. Taran FA, Hesley G, Gorny KR, Stewart E. What factors currently limit magnetic resonance – guided focused ultrasound of leiomyomas? A survey conducted at the first international symposium devoted to clinical magnetic resonance-guided focused ultrasound. Fertil Steril. 2010;94:331–4. Stewart EA, Rabinovici J, Tempany CM, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril. 2006;85(1):22–9. Rabinovici J, David M, Fukunishi M, Morita Y, Gostout BS, Stewart EA, MRgFUS Study Group. Fertil Steril. 2010;93(1):199–209. Stewart EA, Gostout B, Rabinovici J, et al. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007;110(2 Pt 1):279–87. Al Hilli MM, Stewart EA. Magnetic resonance-guided focused ultrasound surgery. Semin Reprod Med. 2010;28(3):242–9. Epub 2010 Apr 22. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100–7. PubMed: 12548202. Stewart EA. Uterine fibroids. Lancet. 2001;357:293–8. PubMed: 11214143. Huyck KL, Panhuysen CI, Cuenco KT, Zhang J, Goldhammer H, Jones ES, et al. The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters. Am J Obstet Gynecol. 2008;198(168):e1–9. PubMed: 18226615. Taran FA, Brown HL, Stewart EA. Racial diversity in uterine leiomyoma clinical studies. Fertil Steril. 2010;94(4):1500–3. Epub 2009 Dec 6. Review. Bouwsma EV, Hesley GK, Woodrum DA, Weaver AL, Leppert PC, Peterson JG, Stewart EA. Comparing focused ultrasound and uterine artery embolization for uterine fibroids – rationale and design of the fibroid interventions: reducing symptoms today and tomorrow (FIRSTT) trial. Fertil Steril. 2011;96(3):704–10. Epub 2011 Jul 27. Hanstede MM, Tempany CM, Stewart EA. Focused ultrasound surgery of intramural leiomyomas may facilitate fertility: a case report. Fertil Steril. 2007;88(2):497.e5–e7. Rabinovici J, Inbar Y, Eylon SC, Schiff E, Hananel A, Freundlich D. Pregnancy and live birth after focused ultrasound surgery for symptomatic focal adenomyosis: a case report. Hum Reprod. 2006;21(5):1255–9. Harding G, Coyne KS, Thompson CL, et al. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL). Health Qual Life Outcomes. 2008;6:99. Orsi F, Arnone P, Chen W, Zhang L. High intensity focused ultrasound: a new therapeutic option for solid tumors. J Cancer Res Ther. 2010;6(4):414–20. Zhang L, Chen WZ, Liu YJ, Hu S, Zhou K, Chen L, et al. Feasibility of magnetic resonance imaging – guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus. Eur J Radiol. 2010;73:396–403. Zowall H, Cairns JA, Brewers C, Lamping DL, Gedroyc WM, Regan L. Cost effectiveness of magnetic resonance-guided focused and ultrasound surgery for treatment of uterine fibroids. BJOG. 2008;115:653–62. O’Sullivan AK, Thompson D, Chu P, Lee DW, Stewart EA, Weinstein MC. Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids. Int J Technol Assess Health Care. 2009;25(1):14–25. Behera MA, Leong M, Johnson L, Brown H. Eligibility and accessibility of magnetic resonance-guided focused ultrasound (MRgFUS) for the treatment of uterine leiomyomas. Fertil Steril. 2010;94(5):1864–8. Author information Authors and Affiliations Corresponding author Editor information Editors and Affiliations Rights and permissions Copyright information © 2014 Springer Science+Business Media New York About this chapter Cite this chapter Richard-Davis, G., Eiland, E. (2014). Focused Ultrasound for Treatment of Fibroids. In: Stadtmauer, L., Tur-Kaspa, I. (eds) Ultrasound Imaging in Reproductive Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9182-8_26 Download citation DOI: https://doi.org/10.1007/978-1-4614-9182-8_26 Published: Publisher Name: Springer, New York, NY Print ISBN: 978-1-4614-9181-1 Online ISBN: 978-1-4614-9182-8 eBook Packages: MedicineMedicine (R0)

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.